Bollon Arthur 4

4 · HEMOBIOTECH, INC. · Filed Dec 17, 2010

Form 4

Period: 2010-12-13

DirectorChief Executive Officer

Transactions

Award
Options to Purchase Common Stock
2009-10-31+96,000→ 196,000 total
Exercise: $0.25From: 2009-10-31Exp: 2014-10-31→ Common Stock (96,000 underlying)
Award
Options to Purchase Common Stock
2009-11-30+26,000→ 222,000 total
Exercise: $0.40From: 2009-11-30Exp: 2014-11-30→ Common Stock (26,000 underlying)
Award
Options to Purchase Common Stock
2009-12-31+21,000→ 243,000 total
Exercise: $0.50From: 2009-12-31Exp: 2014-12-31→ Common Stock (21,000 underlying)
Award
Options to Purchase Common Stock
2010-09-30+7,000→ 250,000 total
Exercise: $0.30From: 2010-09-30Exp: 2015-09-30→ Common Stock (7,000 underlying)
Award
Options to Purchase Common Stock
2010-09-30+19,000→ 269,000 total
Exercise: $0.30From: 2010-09-30Exp: 2015-09-30→ Common Stock (19,000 underlying)

Footnotes (7)

[F1]From October 31, 2009 through December 2009, additional options were granted in lieu of monthly salaries.
[F2]On November 18, 2010, the board of directors of HemoBioTech, Inc. agreed to reprice all options to $.25.
[F3]The Options to Purchase Common Stock were granted on October 31, 2009. All Options are immediately vested and exercisable upon issuance.
[F4]The Options to Purchase Common Stock were granted on November 30, 2009. All Options are immediately vested and exercisable upon issuance.
[F5]The Options to Purchase Common Stock were granted on December 31, 2009. All Options are immediately vested and exercisable upon issuance.
[F6]The Options to Purchase Common Stock were granted on September 30, 2009. All Options are immediately vested and exercisable upon issuance.
[F7]The Options to Purchase Common Stock were granted on September 30, 2009. All Options are immediately vested and exercisable upon issuance.

Documents

1 file